Aspire Biopharma rebrands as Aspire-Lakewood Holdings after Dura Control acquisition

Aspire Biopharma Holdings, Inc.

Corporate name changed to Aspire-Lakewood Holdings, Inc.; effective upon Delaware Certificate of Amendment filing dated Sept 8, 2026.
Nasdaq ticker symbol remains ASBP; no stockholder action required for the name change.
CEO Kraig Higginson cites recent Dura Control Systems Corp. acquisition as the pivot to a diversified holding structure.
DCSC subsidiary holds 310+ patents and operates 11 manufacturing facilities as a tier-one automotive supplier.
Name change approved by board and stockholders under Delaware GCL Section 242.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.